Balyasny Asset Management LLC Johnson & Johnson Transaction History

Balyasny Asset Management LLC

$54.9 Billion
Q2 2024

A detailed history of Balyasny Asset Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Balyasny Asset Management LLC holds 5,410 shares of JNJ stock, worth $866,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,410

Previous 6,500 16.77%

Holding current value

$866,303

Previous $1.03 Million 23.15%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $3.81 Million - $4.17 Million	-26,422 Reduced 83.0%	5,410 $790,000
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $1.35 Million - $1.41 Million	8,691 Added 37.56%	31,832 $5.04 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $24.4 Million - $26.6 Million	-167,542 Reduced 87.86%	23,141 $3.63 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $28.1 Million - $31.4 Million	180,173 Added 1714.3%	190,683 $29.7 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $9.78 Million - $10.5 Million	-63,381 Reduced 85.78%	10,510 $1.74 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $11.1 Million - $13.3 Million	73,769 Added 60466.39%	73,891 $11.5 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $1.53 Million - $1.72 Million	-9,577 Reduced 98.74%	122 $21,000
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $1.56 Million - $1.74 Million	9,699 New	9,699 $1.58 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $36 Million - $40.8 Million	227,359 New	227,359 $40.3 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $91.5 Million - $102 Million	-586,748 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $39 Million - $43.3 Million	241,466 Added 69.93%	586,748 $94.8 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $23.3 Million - $25 Million	146,059 Added 73.31%	345,282 $56.9 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $5.66 Million - $6.31 Million	-37,000 Reduced 15.66%	199,223 $32.7 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $9.66 Million - $11.1 Million	70,450 Added 42.5%	236,223 $37.2 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $3.11 Million - $3.4 Million	-22,128 Reduced 11.78%	165,773 $24.7 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $1.58 Million - $1.91 Million	12,275 Added 6.99%	187,901 $26.4 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $37.6 Million - $43.1 Million	-294,544 Reduced 62.65%	175,626 $25.6 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $45.6 Million - $51 Million	359,150 Added 323.5%	470,170 $60.8 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $11.6 Million - $12.8 Million	88,657 Added 396.45%	111,020 $15.5 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $1.23 Million - $1.36 Million	9,744 Added 77.22%	22,363 $3.13 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $1.51 Million - $1.66 Million	12,619 New	12,619 $1.53 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $13.5 Million - $16 Million	-107,858 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $43 Million - $47 Million	-327,399 Reduced 75.22%	107,858 $15.1 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $56.4 Million - $58.9 Million	435,257	435,257 $56.6 Million

Others Institutions Holding JNJ

# of Institutions

4,219

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Johnson & Johnson Transaction History